Literature DB >> 7262142

Endogenous oestradiol-17beta concentration in breast tumours determined by mass fragmentography and by radioimmunoassay: relationship to receptor content.

M Edery, J Goussard, L Dehennin, R Scholler, J Reiffsteck, M A Drosdowsky.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7262142     DOI： 10.1016/0014-2964(81)90220-6

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN： 0014-2964            Impact factor:   9.162


× No keyword cloud information.
  18 in total

1.  The effect of adjuvant therapy with or without tamoxifen on the endocrine function of patients with breast cancer.

Authors:  T Yasumura; T Akami; M Mitsuo; T Oka; K Naitoh; T Yamamoto; H Honjyo; H Okada
Journal:  Jpn J Surg       Date:  1990-07

Review 2.  The development, application and limitations of breast cancer cell lines to study tamoxifen and aromatase inhibitor resistance.

Authors:  Cynthie Wong; Shiuan Chen
Journal:  J Steroid Biochem Mol Biol       Date:  2012-01-08       Impact factor: 4.292

3.  Influence of endocrine status on biochemical and immunocytochemical estrogen and progesterone receptor assays in breast cancer patients.

Authors:  H J Helin; J J Isola; M J Helle; H Adlercreutz
Journal:  Breast Cancer Res Treat       Date:  1988-09       Impact factor: 4.872

Review 4.  Aromatase inhibitors and inactivators for breast cancer therapy.

Authors:  Per E Lønning
Journal:  Drugs Aging       Date:  2002       Impact factor: 3.923

5.  Estrogen receptor alpha-negative and progesterone receptor-positive breast cancer: lab error or real entity?

Authors:  Jawad Kiani; Afrasyab Khan; Hina Khawar; Fawad Shuaib; Shahid Pervez
Journal:  Pathol Oncol Res       Date:  2006-12-25       Impact factor: 3.201

Review 6.  Mechanisms of action of aminoglutethimide as endocrine therapy of breast cancer.

Authors:  P E Lønning; S Kvinnsland
Journal:  Drugs       Date:  1988-06       Impact factor: 9.546

Review 7.  Aromatase, estrone sulfatase, and 17β-hydroxysteroid dehydrogenase: structure-function studies and inhibitor development.

Authors:  Yanyan Hong; Shiuan Chen
Journal:  Mol Cell Endocrinol       Date:  2010-10-01       Impact factor: 4.102

8.  Estrogen receptor status of breast cancer in Ontario.

Authors:  G E McKeown-Eyssen; I Rogers-Melamed; E A Clarke
Journal:  CMAJ       Date:  1985-11-15       Impact factor: 8.262

Review 9.  The role of aromatase in breast tumors.

Authors:  M J Reed
Journal:  Breast Cancer Res Treat       Date:  1994       Impact factor: 4.872

10.  Development of a high sensitivity, nested Q-PCR assay for mouse and human aromatase.

Authors:  Gui-Jian Liu; Giujian Liu; Yu-Sheen Wu; David Brenin; Wei Yue; Sarah Aiyar; Anne Gompel; Ji-Ping Wang; Rajeshwar Rao Tekmal; Richard J Santen
Journal:  Breast Cancer Res Treat       Date:  2007-11-02       Impact factor: 4.872
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.